FDA approves Abbott’s new spinal cord stimulator

Abbott’s Proclaim Plus spinal cord stimulator received FDA approval.

Advertisement

The device uses Abbot’s FlexBurst360, which helps with chronic pain in six areas of the trunk and limbs, according to an Aug. 23 news release from Abbott. FlexBurst360 is part of Abbott’s proprietary Burst DR therapy that uses mild electrical energy to alter pain signals.

Proclaim Plus has a recharge-free battery lasting up to 10 years and can be used with the NeuroSphere virtual clinic.

Advertisement

Next Up in Spinal Tech

  • The highest-paid CFO of orthopedic medtech companies in the U.S. saw more than $12 million per year in total compensation…

  • Spinal device company Alphatec has commercially launched its Prone TransPsoas corpectomy system.  The launch marks the expansion of Alphatec’s deformity…

Advertisement

Comments are closed.